[Clinical approach to incidental pancreatic cystic lesions].
Cystic lesions of the pancreas are being incidentally recognized with increasing frequency and become a common finding in clinical practice. Despite of recent remarkable advances of radiological and endoscopic assessment and a better understanding of natural history of certain subgroups of cystic lesions, differentiating among lesions and making an optimal management plan is still challenging. A multimodal approach should be performed to evaluate incidentally detected cystic lesions. Emerging evidence supports selective nonoperative management for the majority of patients with cystic lesions, but, for those in whom a suspicion of malignancy remains, surgery is indicated. Concerning long-term follow-up, there is limited data to support the ideal modality, intensity, and duration. Therefore, evidence-based guidelines for the diagnosis, management, and follow-up of cystic lesions of the pancreas should be established.
Lee
Sang Hyub
SH
Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Bundang-gu, Seongnam, Korea. gidoctor@snubh.org
D014408:Biomarkers, Tumor / Q000097:blood; D018282:Cystadenocarcinoma, Mucinous / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D018283:Cystadenocarcinoma, Papillary / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D018284:Cystadenocarcinoma, Serous / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D015994:Incidence; D033162:Incidental Findings; D010181:Pancreatic Cyst / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D014057:Tomography, X-Ray Computed
D014408:Biomarkers, Tumor